Graft-versus-leukemia effect and its clinical implications.

about

Stem Cell Transplantation for Chronic Lymphocytic Leukaemia: Is this the Way Forward in the New Millennium?; Malignancy; Current Clinical Practice.Extramedullary relapse despite graft-versus-leukemia effect after bone marrow transplantation in a girl with juvenile myelomonocytic leukemia.

P2860

Q34278296-8AD004F6-4753-4024-9E2B-C84876DD3CBC Q50756523-540A72DD-D22D-43CD-AFB0-B47419FDB2A9

P2860

Graft-versus-leukemia effect and its clinical implications.

Item

http://www.wikidata.org/entity/Q40920988

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Graft-versus-leukemia effect and its clinical implications.

@en

type

Item

label

Graft-versus-leukemia effect and its clinical implications.

@en

prefLabel

Graft-versus-leukemia effect and its clinical implications.

@en

P1476

Graft-versus-leukemia effect and its clinical implications.

@en

P2093

Hashino S

http://www.w3.org/2001/XMLSchema#string

Imamura M

http://www.w3.org/2001/XMLSchema#string

Tanaka J

http://www.w3.org/2001/XMLSchema#string

P2860

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

Biology of natural killer cells

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.

In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.

Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.

Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

P304

477-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428199609054857

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1996-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9031079

http://www.w3.org/2001/XMLSchema#string

Graft-versus-leukemia effect and its clinical implications.

about

P2860

P2860

Graft-versus-leukemia effect and its clinical implications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698